Biohaven (BHVN) Interest Expenses (2021 - 2026)
Biohaven (BHVN) posted Interest Expenses of $10.9 million for Q1 2026, down 82.23% sequentially from $61.3 million in Q3 2025, and down 92.04% YoY from $136.8 million in Q1 2025.
Biohaven (BHVN) Interest Expenses (2021 - 2026) Analysis & Trends
Biohaven has reported Interest Expenses for 6 years, with the latest figure at $10.9 million in Q1 2026.
- Quarterly Interest Expenses fell 92.04% year-over-year to $10.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.9 million (down 92.04% YoY) and the FY2025 annual result came in at $313.4 million, up 3.17% from the prior year.
- Interest Expenses slipped to $10.9 million in Q1 2026 per BHVN's latest filing, from $61.3 million in the prior quarter.
- Over five years, Interest Expenses peaked at $509.3 million in Q1 2024 and troughed at $86000.0 in Q3 2023.
- A 5-year average of $149.8 million and a median of $61.3 million in 2025 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2023 and 2024: Interest Expenses slumped 98.64% in 2023, then soared 496647.67% in 2024.
- Over 5 years, Interest Expenses stood at $216.1 million in 2022, then rose by 20.08% to $259.4 million in 2023, then advanced by 17.07% to $303.7 million in 2024, then plunged by 79.81% to $61.3 million in 2025, then slumped by 82.23% to $10.9 million in 2026.
- According to Business Quant data, Interest Expenses over the past three periods registered $10.9 million, $61.3 million, and $57.1 million for Q1 2026, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Biohaven | 2.21 Bn | 1.94 Bn | - | 75.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 75.67 Mn |
| Jun 30, 2026 | 75.67 Mn |
| Mar 31, 2026 | 10.90 Mn |
| Mar 31, 2026 | 10.90 Mn |
| Sep 30, 2025 | 61.32 Mn |
| Sep 30, 2025 | 61.32 Mn |
| Jun 30, 2025 | 57.11 Mn |
| Jun 30, 2025 | 57.11 Mn |
| Mar 31, 2025 | 136.82 Mn |
| Mar 31, 2025 | 136.82 Mn |
| Dec 31, 2024 | 303.73 Mn |
| Dec 31, 2024 | 303.73 Mn |
| Sep 30, 2024 | 427.20 Mn |
| Sep 30, 2024 | 427.20 Mn |
| Jun 30, 2024 | 256.02 Mn |
| Jun 30, 2024 | 256.02 Mn |
| Mar 31, 2024 | 509.31 Mn |
| Mar 31, 2024 | 509.31 Mn |
| Dec 31, 2023 | 259.45 Mn |
| Dec 31, 2023 | 259.45 Mn |